Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$884K Sell
16,873
-1,502
-8% -$79.4K 0.08% 181
2026
Q1
$1.01M Sell
18,375
-2,707
-13% -$147K 0.1% 156
2025
Q4
$1.03M Sell
21,082
-543
-3% -$25.3K 0.11% 149
2025
Q3
$933K Sell
21,625
-911
-4% -$35.6K 0.1% 156
2025
Q2
$865K Buy
22,536
+1,957
+10% +$74.8K 0.12% 132
2025
Q1
$797K Sell
20,579
-288
-1% -$10.5K 0.12% 133
2024
Q4
$706K Sell
20,867
-109
-0.5% -$3.92K 0.11% 143
2024
Q3
$857K Buy
20,976
+148
+0.7% +$6.05K 0.13% 135
2024
Q2
$802K Sell
20,828
-1,579
-7% -$66.4K 0.12% 151
2024
Q1
$961K Sell
22,407
-390
-2% -$16.1K 0.14% 146
2023
Q4
$845K Sell
22,797
-172
-0.7% -$6.17K 0.12% 154
2023
Q3
$833K Sell
22,969
-2,007
-8% -$71.2K 0.14% 138
2023
Q2
$890K Sell
24,976
-1,700
-6% -$61K 0.15% 132
2023
Q1
$974K Sell
26,676
-191
-0.7% -$6.68K 0.2% 110
2022
Q4
$957K Buy
26,867
+1,799
+7% +$59.9K 0.22% 107
2022
Q3
$738K Sell
25,068
-23
-0.1% -$872 0.2% 117
2022
Q2
$1.36M Buy
25,091
+1,257
+5% +$69.4K 0.29% 75
2022
Q1
$1.3M Sell
23,834
-1,159
-5% -$63K 0.23% 90
2021
Q4
$1.38M Sell
24,993
-459
-2% -$23.9K 0.24% 95
2021
Q3
$1.29M Buy
+25,452
New +$1.28M 0.24% 95

Other funds holding GSK

Intrua Financial's GSK Position: Q2 2026 in Review

Intrua Financial reduced its GSK (GSK) stake by 8.2% in Q2 2026, selling an estimated $79.4K and leaving 16,873 shares worth $884K. The position accounts for 0.08% of the portfolio, ranked #181.

Intrua Financial first reported a position in GSK in Q3 2021 and has held it in 20 quarters since. The position peaked at $1.38M in Q4 2021. 348 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Intrua Financial held 16,873 shares of GSK worth $884K as of Q2 2026.
  • Intrua Financial sold 1,502 GSK shares in Q2 2026, an estimated $79.4K.
  • GSK made up 0.08% of Intrua Financial's portfolio in Q2 2026, its #181 holding.
  • Intrua Financial first reported a position in GSK in Q3 2021 and has held it in 20 quarters since.
  • Intrua Financial's GSK position peaked at $1.38M in Q4 2021.
  • 348 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Intrua Financial's 13F filing for Q2 2026, filed 24 Jul 2026.